The Valley Desk

ReviewClinical lung cancerPublished

To Stop or Not to Stop: Is It Time to Reevaluate Immunotherapy Duration in Advanced/Metastatic NSCLC?

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Immunotherapy; Biomarkers, Tumor; Immune Checkpoint Inhibitors; Treatment Interruption; Toxicity; Biomarkers; Toxicities; Duration Of Treatment
PubMed ID
42060952
Added to directory
Source checked

Report a correction or request removal